Fluocinonide: Clinical Trials

10 trials of Fluocinonide, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 2 recruiting, 1 terminated, 1 withdrawn. 4 Phase 4, 3 Phase 2, 1 Early Phase 1, 1 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 44Completed 2, Recruiting 2
Phase 23Completed 2, Terminated 1
Early Phase 11Completed 1
Not applicable1Withdrawn 1

Follow Fluocinonide: new trials by email Literature Review of Fluocinonide trials Research Report on Fluocinonide

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of Lidocaine-Dexmedetomidine on Pain, Inflammation, and Oxidative Stress After Bariatric Surgery.
Intravenous Lidocaine infusion + Standard Anesthesia, Intravenous Dexmedetomidine infusion + Standard Anesthesia, Lidocaine + Dexmedetomidine Combination (LIDEX) + Standard Anesthesia - Morbid Obesity Requiring Bariatric Surgery, Postoperative Pain
Phase 4RecruitingInstituto Mexicano del Seguro Social1042025-10-062025-11-28
Effectiveness of Imiquimod Topical Cream in Early Stage Cutaneous T-cell Lymphoma
3.75% Imiquimod Cream, 0.1% Fluocinonide Cream - Mycosis Fungoides
Not applicableWithdrawnRochester General Hospital2020-04-012021-04-27
Treatment Results for Patients With Central Centrifugal Cicatricial Alopecia (CCCA): a Multicenter Prospective Study
Topical steroid class I-II, Triamcinolone Acetonide, Doxycyline - Central Centrifugal Cicatricial Alopecia (CCCA)
Phase 4RecruitingWake Forest University Health Sciences2502018-04-302026-03-31
Cutaneous Lupus Medication Experience Study
fluocinonide 0.05% cream - Cutaneous Lupus
CompletedWake Forest University Health Sciences112014-12-012025-04-24
Using an Internet Study to Improve Adherence for Psoriasis Patients
Internet Survey, fluocinonide 0.05% ointment - Psoriasis
Early Phase 1CompletedWake Forest University402012-10-012020-06-04
Efficacy of Fluocinonide Cream 0.1% (Vanos(R)) in Reducing Itch in Subjects With Atopic Dermatitis
Fluocinonide cream - Atopic Dermatitis
Phase 2CompletedWake Forest University102012-02-012018-09-07
Fluocinonide Cream in Treating Symptoms of Vaginal Dryness and Painful Sexual Intercourse In Patients With Breast Cancer Undergoing Hormone Therapy
Fluocinonide Cream, Management of Therapy Complications, Questionnaire Administration - Breast Carcinoma
Phase 2CompletedOHSU Knight Cancer Institute342011-09-012017-08-09
A Study Evaluating the Efficacy of Fluocinonide Cream 0.1% (Vanos) in Subjects With Atopic Dermatitis
Fluocinonide Cream 0.1% - Atopic Dermatitis
Phase 4CompletedWake Forest University Health Sciences202009-03-012018-08-01
VANOS Cream and Skin Barrier Function
Fluocinonide - Atopic Dermatitis
Phase 4CompletedOregon Health and Science University252009-01-012017-07-11
Sorafenib-induced Hand- Foot Skin Reaction Treatment
urea 40% cream, fluocinonide 0.05% cream, tazarotene 0.1% cream - Hand-foot Skin Reaction, Rash
Phase 2TerminatedNorthwestern University62008-06-012013-06-05

Conditions studied

Dermatitis, Atopic (3)  ·  Eczema (2)  ·  Agnosia (1)  ·  Alopecia (1)  ·  Breast Neoplasms (1)  ·  Exanthema (1)  ·  Lymphoma, T-Cell, Cutaneous (1)  ·  Mycosis Fungoides (1)  ·  Pain, Postoperative (1)  ·  Pruritus (1)  ·  Psoriasis (1)

Sponsors

Wake Forest University Health Sciences (3)  ·  Wake Forest University (2)  ·  Instituto Mexicano del Seguro Social (1)  ·  Northwestern University (1)  ·  OHSU Knight Cancer Institute (1)  ·  Oregon Health and Science University (1)  ·  Rochester General Hospital (1)

Countries

United States (8)  ·  Mexico (1)

Top investigators

Steven R Feldman, MD, PhD (2)  ·  Amy J McMichael, MD (1)  ·  Arnulfo Calixto Flores, Prof MD, PhD (1)  ·  Brian Poligone, M.D. Ph.D. (1)  ·  Dennis West, PhD (1)  ·  Kathleen Kemmer (1)  ·  Steven Feldman, MD, PhD (1)  ·  William W Huang, MD, MPH, FAAD (1)

Results publications

PMID 11737181, PMID 18499604, PMID 19020142, PMID 19573663, PMID 20740215, PMID 24036842, PMID 25785316, PMID 25929655, PMID 26889627, PMID 26903197, PMID 30117019, PMID 31687018, PMID 31958741, PMID 32240402, PMID 32533519, PMID 32632956, PMID 32778146, PMID 33407156, PMID 33623424, PMID 34704710, PMID 35090535, PMID 35422388, PMID 36463344, PMID 37297968, PMID 37542100, PMID 37554513, PMID 38085848, PMID 38792558, PMID 38827237, PMID 39663167, PMID 7397378

NIH funding

P30CA069533 (1)